MICHELLE ARIAS-BORRERO: Open Payments
NPI 1043248057 · BREWSTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,274 in 160 payments from 16 companies in 2025. Trend: 2023 $3,447 · 2024 $3,302 · 2025 $4,274
Food & beverage: $4,274
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $841 |
| ABBVIE INC. | 23 | $695 |
| Novo Nordisk Inc | 22 | $694 |
| Lilly USA, LLC | 21 | $476 |
| Corcept Therapeutics | 18 | $286 |
| Abbott Laboratories | 3 | $229 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $209 |
| GlaxoSmithKline, LLC. | 14 | $203 |
| Madrigal Pharmaceuticals | 1 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $136 |
Products named: VRAYLAR, MOUNJARO, BREZTRI, Korlym, Wegovy, TEZSPIRE, Ozempic, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
